Chlorpheniramine/ Pyrilamine/ Phenylephrine/ Phenylpropanolamine: Who Should Not Take Chlorpheniramine Pyrilamine Phenylephrine Phenylpropanolamine

Content provided by Cerner Multum, Inc.

Who should not take chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine?

Do not take chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have

• kidney disease,
• liver disease,
• diabetes,
• glaucoma,
• any type of heart disease or high blood pressure,
• thyroid disease,
• emphysema or chronic bronchitis, or
• difficulty urinating or an enlarged prostate.

You may not be able to take chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.

Chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant.

This medication passes into breast milk and may harm a nursing baby. Do not take this medication without first talking to your doctor if you are breast-feeding a baby.

If you are over 65 years of age, you may be more likely to experience side effects from chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine. You may require a lower dose of this medication.

Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

E-mail This | Print This Previous Chapter | Next Chapter

Last updated:	February 13, 2004